The Retatrutide + Tirzepatide Pen (30mg/30mg combo) is an Exclusive product by Windsor Glow.
It is a pre-mixed dual-compound research instrument pen combining Retatrutide, a triple agonist activating GLP-1, GIP and glucagon receptors, with Tirzepatide a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist.
Together the two compounds engage complementary appetite-regulation and metabolic pathways, of particular interest for advanced metabolic-health research beyond what is typically modelled with a single GLP-1 agonist alone.
From the research shown this is the most powerful combination of the 2 biggest GLP-1 products.
Available 30mg/30mg pre-dosed formats.
Designed for laboratory use by qualified researchers.